(Alliance News) - London's FTSE 100 opened in the green on Wednesday as China criticises the US-UK trade deal, and gold prices continue to weaken amid easing global tariff tension.

Diluted earnings per share improved to 54.1 US cents from 50.4 cents. For financial 2025, Compass continues to expect high single-digit underlying operating profit growth driven by organic revenue ...

In early corporate news, luxury goods company Burberry said it will cut up to 1,700 jobs globally as it swings to a loss against a "difficult macroeconomic backdrop", and pharmaceuticals firm GSK ...

(Alliance News) - China has criticised the UK-US trade deal in a potential blow to the government's bid to revive relations with the country. Beijing said it was a "basic principle" that such ...

(Alliance News) - London's FTSE 100 is set to open in the red on Wednesday, as new research reveals UK holidaymakers are tightening their purses amid concerns on living costs and following US ...

Among the offices being closed in London is 102 Petty France, one of the largest government offices in the capital and home to around 7,000 civil servants in the Ministry of Justice, HM Courts & ...

The research also found that frustrations with hotels expressed by some holidaymakers included the cost of "extras", unreliable wifi and the cost of dining. 59% of people said they are making changes ...

Matt Brewis, director of insurance at the FCA, said: "We are stripping back our insurance rule book by removing ineffective, outdated or duplicated regulation, as part of our drive to become a smarter ...

(Alliance News) - StreaksAI PLC shares surged on Tuesday as it said it has rebranded as TAO Alpha PLC to show its "commitment to innovation".

(Alliance News) - ECR Minerals PLC on Tuesday said it has terminated discussions to buy Maximus Minerals Ltd due to "unforeseen structural challenges" at Maximus. The gold-focused exploration and ...

(Alliance News) - Tullow Oil PLC on Tuesday said it has signed a sale and purchase agreement to sell its Gabon assets to Gabon Oil Company for USD300 million.

The drug was being developed as a potential treatment for various cancers. GSK said it is expanding from its current focus on blood and women's cancers into lung and gastrointestinal cancers, as well ...